Cholinesterase targeting by polyphenols: A therapeutic approach for the treatment of Alzheimer's disease

CNS Neuroscience & Therapeutics
Nasimudeen R JabirShams Tabrez

Abstract

Alzheimer's disease (AD) is a progressive irreversible neurodegenerative disorder characterized by excessive deposition of β-amyloid (Aβ) oligomers, and neurofibrillary tangles (NFTs), comprising of hyperphosphorylated tau proteins. The cholinergic system has been suggested as the earliest and most affected molecular mechanism that describes AD pathophysiology. Moreover, cholinesterase inhibitors (ChEIs) are the potential class of drugs that can amplify cholinergic activity to improve cognition and global performance and reduce psychiatric and behavioral disturbances. Approximately, 60%-80% of all cases of dementia in the world are patients with AD. In view of the continuous rise of this disease especially in the aged population, there is a dire need to come up with a novel compound and/or mixture that could work against this devastating disease. In this regard, the best is to rely on natural compounds rather than synthetic ones, because natural compounds are easily available, cost-effective, and comparatively less toxic. To serve this purpose, lately, scientific community has started exploring the possibility of using different polyphenols either solitary or in combination that can serve as therapeutics against AD. In the curr...Continue Reading

References

Jun 6, 2000·The American Journal of Clinical Nutrition·H Mukhtar, N Ahmad
Aug 2, 2003·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·A G RenwickR Kroes
Jan 6, 2004·Free Radical Research·Amanpreet SinghShrinivas K Kulkarni
Sep 25, 2004·Bioscience, Biotechnology, and Biochemistry·Hye Kyung KimJoo Ho Chung
Sep 3, 2005·Antiviral Research·Jae-Min SongBaik-Lin Seong
Jan 20, 2006·The European Journal of Neuroscience·Stéphane BastianettoRémi Quirion
May 30, 2006·Nature Reviews. Drug Discovery·Joseph A Baur, David A Sinclair
Nov 2, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jun WangGiulio Maria Pasinetti
Oct 27, 2007·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mankil Jung, Moonso Park
Feb 16, 2008·Zeitschrift Für Naturforschung. C, a Journal of Biosciences·Ilkay OrhanBilge Sener
Mar 8, 2008·Cellular and Molecular Life Sciences : CMLS·H HatcherS V Torti
Mar 15, 2008·Phytotherapy Research : PTR·Moon Hee JangJeong Hill Park
Mar 29, 2008·Antioxidants & Redox Signaling·Alexios S Strimpakos, Ricky A Sharma
Jun 20, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jun WangGiulio M Pasinetti
May 16, 2009·Stroke; a Journal of Cerebral Circulation·Eric E Smith, Steven M Greenberg
May 19, 2009·European Journal of Medicinal Chemistry·A A N de PaulaR Gargano
Jul 15, 2009·Chemico-biological Interactions·Mahmud Tareq Hassan KhanT Slapetová
Nov 3, 2009·European Journal of Medicinal Chemistry·Maja KatalinićZrinka Kovarik
Apr 24, 2010·Human Molecular Genetics·Leslie Crews, Eliezer Masliah
Jun 5, 2010·Acta Pharmacologica Sinica·Ying WangHai-yan Zhang
Jan 1, 2009·Frontiers in Aging Neuroscience·Charlotte A OomenPeter Meerlo
Aug 27, 2010·Zeitschrift Für Naturforschung. C, a Journal of Biosciences·Cláudia SeidlCid A M Santos
Jan 12, 2011·Neurochemical Research·Mostafa RahvarAli Akbar Owji
Jan 14, 2011·Pharmacology·Kunlin JinDavid A Greenberg
Mar 26, 2011·Journal of Agricultural and Food Chemistry·Ji Young KimKi Hun Park
Oct 18, 2011·CNS & Neurological Disorders Drug Targets·Shazi ShakilMohammad A Kamal
Jan 10, 2012·Cold Spring Harbor Perspectives in Medicine·Alberto Serrano-PozoBradley T Hyman
Jan 19, 2012·Nutrients·Rong Tsao
Mar 1, 2012·Neurochemistry International·Ravichandran SrividhyaPeriandavan Kalaiselvi
Jun 22, 2012·International Journal of Alzheimer's Disease·Natalia Crespo-BielFred Van Leuven

❮ Previous
Next ❯

Citations

Feb 19, 2019·Journal of Drug Targeting·Badar Ul IslamShams Tabrez
Jan 15, 2020·Molecular Biology Reports·Mehjbeen JavedSufia Naseem
Dec 11, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Shyam Sharan ShresthaSangeeta Rajbhandary
Dec 24, 2019·JAD Reports·Anuja Sharma, Yatender Kumar
Nov 16, 2018·Applied Biochemistry and Biotechnology·Márcia Fernanda Correia Jardim PazAna Amélia de Carvalho Melo-Cavalcante
Jul 2, 2019·Current Pharmaceutical Design·Shams Tabrez, Ghazi A Damanhouri
Jan 19, 2019·International Journal of Molecular Sciences·Francesco PotìIlaria Zanotti
Nov 16, 2019·CNS Neuroscience & Therapeutics·Meng-Yan HuWei Cai
Dec 28, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ana Teresa SilvaPaula Gomes
Apr 3, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Shyam Sharan ShresthaSangeeta Rajbhandary
Feb 6, 2021·Brain Sciences·Hafsa Amat-Ur-RasoolWayne G Carter
Dec 15, 2019·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Mohamad Fawzi MahomoodallyGokhan Zengin
Nov 19, 2020·Biomolecules·Hafsa Amat-Ur-RasoolWayne G Carter
Mar 23, 2021·Dose-response : a Publication of International Hormesis Society·Usman JavaidImran Imran
May 6, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Maram B AlhawarriHabibah A Wahab
Jul 25, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Boris NemzerNebiyu Abshiru
Aug 11, 2021·Plants·Antonella FaisFrancesca Pintus
Oct 9, 2021·Natural Product Research·Amal SallamMarwa Elsbaey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Related Papers

Acta Biochimica Et Biophysica Sinica
Weihua WangQuanhong Ma
International Journal of Biological Macromolecules
Badar Ul Islam, Shams Tabrez
Current Topics in Medicinal Chemistry
Badar Ul IslamShams Tabrez
© 2022 Meta ULC. All rights reserved